SAMPLE SIZES FOR EVENT RATE EQUIVALENCE TRIALS USING PRIOR INFORMATION

被引:20
作者
GOULD, AL
机构
[1] Merck Research Laboratories, Pennsylvania, 19486, BL3-2, West Point
关键词
D O I
10.1002/sim.4780122105
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Trials for demonstrating the 'equivalence' of active standard and test treatments generally require large sample sizes that depend on the definition of 'equivalence' and the overall event rate when the outcome is incidence of an event such as mortality. The planning of sample sizes for such trials requires specification of a value For the overall event rate. This value often will reflect the outcomes of previous trials of the standard treatment, and is subject to uncertainty that needs some accommodation, to protect against an inadequate sample. Bayes and Empirical Bayes methods can be used to incorporate information from one or more previous trials into the sample size calculation when equivalence means high confidence that the event rate ratio is less than some specified value.
引用
收藏
页码:2009 / 2023
页数:15
相关论文
共 20 条
[1]   BAYESIAN RISK RATIO ANALYSIS [J].
AITCHISON, J ;
BACONSHONE, J .
AMERICAN STATISTICIAN, 1981, 35 (04) :254-257
[2]   PROVING THE NULL HYPOTHESIS IN CLINICAL-TRIALS [J].
BLACKWELDER, WC .
CONTROLLED CLINICAL TRIALS, 1982, 3 (04) :345-353
[3]   AN INTRODUCTION TO EMPIRICAL BAYES DATA-ANALYSIS [J].
CASELLA, G .
AMERICAN STATISTICIAN, 1985, 39 (02) :83-87
[4]   A COMPARISON OF ENALAPRIL WITH HYDRALAZINE ISOSORBIDE DINITRATE IN THE TREATMENT OF CHRONIC CONGESTIVE-HEART-FAILURE [J].
COHN, JN ;
JOHNSON, G ;
ZIESCHE, S ;
COBB, F ;
FRANCIS, G ;
TRISTANI, F ;
SMITH, R ;
DUNKMAN, WB ;
LOEB, H ;
WONG, ML ;
BHAT, G ;
GOLDMAN, S ;
FLETCHER, RD ;
DOHERTY, J ;
HUGHES, CV ;
CARSON, P ;
CINTRON, G ;
SHABETAI, R ;
HAAKENSON, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (05) :303-310
[6]   CONFIDENCE INTERVALS FOR POWER, WITH SPECIAL REFERENCE TO MEDICAL TRIALS [J].
DUDEWICZ, EJ .
AUSTRALIAN JOURNAL OF STATISTICS, 1972, 14 (03) :211-216
[7]   SIGNIFICANCE TESTING TO ESTABLISH EQUIVALENCE BETWEEN TREATMENTS, WITH SPECIAL REFERENCE TO DATA IN FORM OF 2 X 2 TABLES [J].
DUNNETT, CW ;
GENT, M .
BIOMETRICS, 1977, 33 (04) :593-602
[8]   PLANNING AND MONITORING OF EQUIVALENCE STUDIES [J].
DURRLEMAN, S ;
SIMON, R .
BIOMETRICS, 1990, 46 (02) :329-336
[10]  
GOULD AL, 1988, BIOPHARMACEUTICAL ST, P509